Literature DB >> 24682738

Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease.

Natasa Kustrimovic1, Emanuela Rasini, Massimiliano Legnaro, Franca Marino, Marco Cosentino.   

Abstract

Dopamine (DA) is a crucial transmitter in the neuroimmune network, where it contributes to the nervous system-immune system interplay as well as in the communication among immune cells. DA acts through five different dopaminergic receptors (DR) grouped into two families: the D1-like (D1 and D5) and the D2-like (D2, D3 and D4). By use of 5-color flow cytometric analysis, we examined the expression of DR on human CD4+ naive T lymphocytes (CD3+CD4+CD45RA+CCR7+), central memory (TCM, CD3+CD4+CD45RA-CCR7+) and effector memory T cells (TEM, CD3+CD4+CD45RA-CCR7-). In addition, in cultured CD4+ T cells we investigated the changes in DR expression induced by stimulation with antiCD3/antiCD28 antibodies. Results showed that CD4+ T cells always expressed all the five DR: D1-like DR were identified on average on 11.6-13.1 % and D2-like DR on 3.1-8.1 % of the cells. DR on CD4+ naive T cells, TCM, and TEM had distinct expression patterns: naive T cells expressed more D1-like than D2-like DR, which on the contrary were increased in TCM and TEM cells. In cultured CD4+ T cells stimulation with anti-CD3/anti-CD28 antibodies increased the expression of D1-like DR by 71-84 % and of D2-like DR by 55-97 %. The frequency of DR was higher in apoptotic cells in comparison to viable cells, however stimulation increased all DR on viable cells, without affecting their expression on apoptotic cells. The present results contribute to unravel the complexity of dopaminergic pathways in human CD4+ T lymphocytes, suggesting their involvement in memory functions as well as in apoptotic processes. In view of the role of CD4+ memory T cells in neuroinflammation and neurodegeneration during Parkinson's disease, the relevance of these findings must be assessed in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682738     DOI: 10.1007/s11481-014-9541-5

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  42 in total

1.  Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study.

Authors:  F McKenna; P J McLaughlin; B J Lewis; G C Sibbring; J A Cummerson; D Bowen-Jones; R J Moots
Journal:  J Neuroimmunol       Date:  2002-11       Impact factor: 3.478

2.  Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.

Authors:  Michal J Besser; Yonatan Ganor; Mia Levite
Journal:  J Neuroimmunol       Date:  2005-09-15       Impact factor: 3.478

3.  Cutting Edge: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation.

Authors:  Chandrani Sarkar; Shamik Das; Debanjan Chakroborty; Uttio Roy Chowdhury; Biswarup Basu; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods.

Authors:  H Lecoeur; E Ledru; M C Prévost; M L Gougeon
Journal:  J Immunol Methods       Date:  1997-12-01       Impact factor: 2.303

5.  Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis.

Authors:  Marco Cosentino; Mauro Zaffaroni; Marco Ferrari; Franca Marino; Raffaella Bombelli; Emanuela Rasini; Gianmario Frigo; Angelo Ghezzi; Giancarlo Comi; Sergio Lecchini
Journal:  J Neuroimmunol       Date:  2005-05       Impact factor: 3.478

6.  HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines.

Authors:  M Cosentino; R Bombelli; M Ferrari; F Marino; E Rasini; G J Maestroni; A Conti; M Boveri; S Lecchini; G Frigo
Journal:  Life Sci       Date:  2000-12-08       Impact factor: 5.037

7.  Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism.

Authors:  J Bas; M Calopa; M Mestre; D G Molleví; B Cutillas; S Ambrosio; E Buendia
Journal:  J Neuroimmunol       Date:  2001-02-01       Impact factor: 3.478

8.  Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity.

Authors:  Gustavo E A Brito-Melo; Rodrigo Nicolato; Antonio Carlos P de Oliveira; Gustavo B Menezes; Felipe J N Lélis; Renato S Avelar; Juliana Sá; Moisés Evandro Bauer; Bruno R Souza; Antonio L Teixeira; Helton José Reis
Journal:  J Psychiatr Res       Date:  2012-04-11       Impact factor: 4.791

9.  Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.

Authors:  F Amenta; E Bronzetti; L Felici; A Ricci; S K Tayebati
Journal:  J Auton Pharmacol       Date:  1999-06

10.  Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis.

Authors:  Mauro Zaffaroni; Franca Marino; Raffaella Bombelli; Emanuela Rasini; Marta Monti; Marco Ferrari; Angelo Ghezzi; Giancarlo Comi; Sergio Lecchini; Marco Cosentino
Journal:  Exp Neurol       Date:  2008-09-12       Impact factor: 5.330

View more
  24 in total

1.  The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications.

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2015-12-16       Impact factor: 4.147

2.  Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1-like receptor agonist: Fenoldopam.

Authors:  Aviad Keren; Amos Gilhar; Yehuda Ullmann; Marina Zlotkin-Frušić; Yoram Soroka; Abraham J Domb; Mia Levite
Journal:  Immunology       Date:  2019-11       Impact factor: 7.397

3.  Dopaminergic and Adrenergic Pathways as Targets for Drug Repurposing in the Neuroimmune Network.

Authors:  Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2020-02-26       Impact factor: 4.147

4.  Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.

Authors:  Giulia Ambrosi; Natasa Kustrimovic; Francesca Siani; Emanuela Rasini; Silvia Cerri; Cristina Ghezzi; Giuseppe Dicorato; Sofia Caputo; Franca Marino; Marco Cosentino; Fabio Blandini
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

Review 5.  Dopamine, T cells and multiple sclerosis (MS).

Authors:  Mia Levite; Franca Marino; Marco Cosentino
Journal:  J Neural Transm (Vienna)       Date:  2017-03-10       Impact factor: 3.575

Review 6.  Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.

Authors:  Christoffer Polcwiartek; Torkel Vang; Christina Hedegård Bruhn; Nasseh Hashemi; Mary Rosenzweig; Jimmi Nielsen
Journal:  Psychopharmacology (Berl)       Date:  2016-09-04       Impact factor: 4.530

Review 7.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

8.  Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.

Authors:  Vicente Lieberknecht; Stella C Junqueira; Mauricio P Cunha; Thaís A Barbosa; Luiz F de Souza; Igor S Coelho; Adair R S Santos; Ana Lúcia S Rodrigues; Alcir L Dafré; Rafael C Dutra
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

9.  Age-Related Dopaminergic Innervation Augments T Helper 2-Type Allergic Inflammation in the Postnatal Lung.

Authors:  Wei Wang; Jonathan A Cohen; Antonia Wallrapp; Kenneth G Trieu; Juliana Barrios; Fengzhi Shao; Nandini Krishnamoorthy; Vijay K Kuchroo; Matthew R Jones; Alan Fine; Yan Bai; Xingbin Ai
Journal:  Immunity       Date:  2019-11-19       Impact factor: 31.745

Review 10.  Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.

Authors:  R Lee Mosley
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.